Elanco Animal Health Incorporated Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Elanco Animal Health Incorporated regarding a class action lawsuit related to misleading statements and omissions concerning the safety and approval timelines of certain products [1][2]. Group 1: Allegations - The complaint alleges that during the class period from November 7, 2023, to June 26, 2024, Elanco made materially false and misleading statements about the safety of Zenrelia, a canine dermatology product [2]. - It is claimed that Elanco was unlikely to meet its previously issued timeline for the U.S. approval and commercial launch of Zenrelia and Credelio Quattro, a parasiticide for dogs [2]. - The allegations suggest that Elanco's business and financial prospects were overstated, leading to materially false public statements [2]. Group 2: Class Action Details - Shareholders who purchased shares of ELAN during the specified class period are encouraged to register for the class action, with a deadline set for December 6, 2024 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].